Cargando…
Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study
BACKGROUND: Pre-clinical studies have shown that furosemide slows cancer cell growth by acting on the Na-K-2Cl transporter, particularly for gastric cancer cells. However, epidemiological studies have not investigated furosemide use and mortality in gastroesophageal cancer patients. Consequently, we...
Autores principales: | Liu, Peipei, McMenamin, Úna C., Spence, Andrew D., Johnston, Brian T., Coleman, Helen G., Cardwell, Chris R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819347/ https://www.ncbi.nlm.nih.gov/pubmed/31664951 http://dx.doi.org/10.1186/s12885-019-6242-8 |
Ejemplares similares
-
Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review
por: Spence, Andrew D., et al.
Publicado: (2017) -
Coffee consumption by type and risk of digestive cancer: a large prospective cohort study
por: Tran, Kim Tu, et al.
Publicado: (2019) -
Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
por: Liu, Peipei, et al.
Publicado: (2020) -
Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study
por: McMenamin, Úna C., et al.
Publicado: (2018) -
Commonly used medications and endometrial cancer survival: a population-based cohort study
por: Sanni, Omolara B, et al.
Publicado: (2017)